Dr. Baseler was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Purdue University and the National Institute of Allergy and Infectious Diseases, July 2010 - 2015. 

Dr. Baseler received her B.S. and M.S. from Iowa State University. She also completed her D.V.M. degree at Iowa State University (2010). She began her graduate fellowship and pathology training in July of 2010 at Purdue University. After completion of the initial diagnostic pathology and pre-dissertation research training at the university, she relocated to Hamilton, MT for her dissertation research on emerging viral infections including Nipah virus and the Middle East respiratory syndrome (MERS) coronavirus, with Heinz Feldmann, M.D., Ph.D., at the National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories.  She received a travel award to present her work at the 32nd annual meeting of the American Society for Virology, State College, PA, July 20-24, 2013.“Histological Comparison Of Respiratory Tract Lesions In Hamsters Intranasally Inoculated With Nipah Virus Isolated From Malaysia Or Bangladesh.”

Upon recieving her Ph.D. in 2015, her career took her to the University of Texas MD Anderson Cancer Center as an asssistant professor.  In July of 2017, she moved to British Columbia, Canada to work at the University of British Columbia and the Animal Health Centre as a veterinary pathologist specializing in fish pathology, while still maintaining her position at the University of Texas MD Anderson Cancer Center.

Dr. Zadrozny was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Heart, Lung, and Blood Institute, 2008 - 2015. 

Dr. Zadrozny received her B.S. from the University of Vermont and her D.V.M. from North Carolina State University (2008) where she also completed a residency in veterinary anatomic pathology. Her dissertation research was accomplished in  the NHLBI Laboratory of Cardiac Energetics, where she studied the aortic macromolecular microstructure in healthy and diseased SR-BI KO/ApoER61h/h mice, a recently defined model of diet-inducedocclusive coronary atherosclerosis and coronary heart disease.  Her research interests are in modeling the functional pathophysiology of cardiovascular disease, with an emphasis on athersclerosis. Her Ph.D. dissertation studies were headed by principal investigator mentor Robert Balaban, Ph.D.  Members of her graduate guidance committee included Robert Balaban, Ph.D., John Cullen, V.M.D., Ph.D., Diplomate, The American College of Veterinary Pathologists, Mark Simpson, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists, and Edward Neufeld, Ph.D.

Dr. Gary was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Cancer Institute, 2009 - 2015. 

 Joy Gary received her B.S. in biology from Davidson College in North Carolina (2005) and her DVM from Colorado State University in 2009. She completed her didactic graduate studies and core diagnostic experience in veterinary anatomic pathology at Michigan State University. She continued her training in pathology and research in the Laboratory of Cancer Biology and Genetics for her dissertation work under the mentorship of Dr. Beverly Mock. She studied the role of an allelic variant of mTOR in BALB/c mice (R628C; C1977T) on the function of the protein as a kinase and in DNA damage repair.  She utilized a mouse that expresses the BALB/c allele of mTOR on a BL6;129 background to explore this allelic variant.  Members of her graduate committee included: Matti Kiupel, Dr. Med. Vet., Ph.D., Diplomate, The American College of Veterinary Pathologists (ACVP), Michigan State University; Beverly Mock, Ph.D, LCBG, NCI; Vilma Yuzbasiyan-Gurkan, Ph.D., Michigan State University; Jennifer Thomas, D.V.M. Ph.D., Michigan State University; and Joshua Webster, Ph.D., Diplomate, The American College of Veterinary Pathologists.

Dr. Gary presented her work, “Decreased mTOR Delays Thymic lymphoma Formation and Leads to Concurrent Down Regulation of CDK6 in Mice with Constitutively Activated Thymic AK”, at the annual meeting of the American Association of Cancer Research, Washington, D.C., April 2013. 

Dr. Davis was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Institute of Allergy and Infectious Diseases, 2007-2014. 

She conducted her Ph.D. dissertation research in the laboratory of Dr. Jeffery K. Taubenberger, M.D.,Ph.D., Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH. Dr. Davis received her D.V.M. and Residency Certificate in Veterinary Anatomic Pathology in 2007 and 2009 respectively from North Carolina State University College of Veterinary Medicine. She also has a BA in Computer Science modified with education and a graduate certificate in secondary school science education from Dartmouth College. 

Currently, Dr. Davis leads scienfic operations at a startup in the cellular agriculture space. Specifically, she is working on making seafood delicacies outside of animals using in vitro techniques. Laboratory operations are based in Sacramento, CA. Dr. Davis is active in multiple scientific professional societies including senior leadership roles in the Histochemical Society and also serves on the editorial boards of the Journal of Histochemistry and Cytochemistry as well as the Veterinary Pathology. 

Prior, as an Assistant Professor for Experimental Veterinary Pathology at Kansas State University and Extraordinary Faculty at the University of Pretoria, Dr. Davis focused on the comparative pathogenesis as well as development of detection and mitigation techniques for several transboundary animal diseases of relevance to production animal agriculture including zoonotic emerging viruses such as Rift Valley fever virus, African swine fever virus as well as SARS-CoV-2.

At the NIAID her research focused on the comparative pathogenesis and response of a diversity of mammalian species to a variety of influenza A viruses, including reconstructed 1918 and 2009 H1N1 pandemic strains. Additionally, she studied the interspecies variability in host response to influenza A virus via in vivo experimentation, digital and light histopathology, immunohistochemistry and immunofluorescence. While at NIAID, she focused on methods development in the following areas:  diminishing autofluorescence in formalin-fixed, paraffin-embedded tissue, multi-label antibody and lectin based immunofluorescence, and validation of the in vitro cell models against human/animal tissues of origin.  This work led to additional collaborations in other areas of respiratory pathology.  Her graduate committee members included: Jeffery Taubenberger, M.D., Ph.D. (co-chair), J. Mac Law, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists (co-chair), James Shelhamer, M.D., Deputy Chief, Critical Care Medicine Department, Clinical Center, NIH and Fred Fuller, Ph.D., North Carolina State University, College of Veterinary Medicine.

Dr. Moore was a scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Institute of Allergy and Infectious Diseases, 2007-2014. 

Dr. Moore received his B.S. from Tuskegee University and his DVM from Tuskegee University School of Veterinary Medicine in 2006, and following graduation, entered a residency in anatomic pathology the Diagnostic Center for Population and Animal Health, Michigan State University. Following completion of initial diagnostic pathology training, Dr. Moore carried out his Ph.D. diossertation work in the NIAID’s Laboratory of Infectious Disease (LID) where, under the guidance of Dr. Kanta Subbarao, he studied the pathologic and immunologic responses of the ferret to wild-type Influenza virus infection. Dr. Moore’s PhD committee was chaired by Kurt Williams DVM, Ph.D., Diplomate, The American College of Veterinary Pathologists.

Dr. Moore presented his work, “The Association of Age and Clinical Disease in Ferrets Infected with Pandemic H1N1 Influenza Virus”, at the 32nd annual meeting of the American Society for Virology, State College, PA, July 20-24, 2013. He also presented at the American College of Veterinary Pathologists’ November 2013 meeting in Montreal, Quebec, Canada. His talk was titled, “Avian Influenza Virus And Central Nervous System (CNS) Infection In Ferrets: A Proposed Novel Route For CNS Invasion”.

His research interests include mechanisms of infectious disease in animal models.  He is currenlty employed by the National Institute of Allergy and Infectious Diseases as a veterinary pathologist, in Rockville, MD.

Dr. Martin was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with University of Maryland and the National Cancer Institute, 2005 – 2014. 

Dr. Martin received his B.S. from Northwestern University, his M.S. from Ohio University and his D.V.M. from Kansas State University in 2003. After completing the D.V.M. Dr. Martin went to the University of California, Davis for residency training in anatomic pathology in the Department of Veterinary Pathology. As an anatomic pathology resident Dr. Martin pursued specialty track training in the pathology of laboratory animals and undertook training in the UC Davis Comparative Pathology Laboratory and the Pathology Department of the California Regional Primate Center. In 2005 Dr. Martin began training in comparative pathology through the Graduate Partnership Program at the National Cancer Institute, Bethesda MD. The first year of the GPP program was spent completing graduate course work at the University of Maryland and in additional anatomic pathology training while working in the Comparative Molecular Pathology Unit with Dr. Mark Simpson. Dr. Martin accomplished board certification in Anatomic Pathology by The American College of Veterinary Pathologists in 2006. Dr. Martin is carried out his dissertation research in the NCI Laboratory of Genitourinary Cancer Pathogenesis, headed by Kathy Kelly, PhD. His Ph.D. dissertation research involved developing an in-vivo bioluminescent transgenic mouse model of prostate cancer metastasis for the purpose of investigating the molecular signaling mechanisms responsible for driving prostate cancer metastasis. Members of his graduate guidance committee included Siba Samal, B.V.Sc., Ph.D., Diplomate, The American College of Veterinary Microbiologists (chair), Xiaoping Zhu, D.V.M., Ph.D., Robert Dooling, Ph.D., Kathy Kelly, Ph.D., and Mark Simpson, D.V.M., Ph.D, Diplomate, The American College of Veterinary Pathologists. Upon receiving his Ph.D., Dr. Martin worked as a veterinary pathologist for the NCI Frederick’s Center for Advanced Preclinical Research.  He currently is employed by MedImmune/AstraZeneca.

Dr. Osborne was a graduate scholar in the NCI molecular pathology GPP in partnership with the University of Illinois, Urbana-Champaign and the National Cancer Institute, from 2006 to 2010. 

Dr. Tanasa Osborne received her Doctorate of Veterinary Medicine (DVM) from Tuskegee University College of Veterinary Medicine in 2002. That same year, Dr. Osborne entered a combined residency/PhD training program in anatomic pathology with an emphasis on toxicologic pathology in the Department of Pathobiology at the University of Illinois at Urbana-Champaign. Upon completion of her residency in 2006 Dr. Osborne began graduate training in comparative pathology through the GPP at the NCI, Bethesda, MD. Her PhD dissertation research in metastasis biology was carried out in the Tumor and Metastasis Biology Section, headed by Chand Khanna, DVM, PhD in the Pediatric Oncology Branch. Her model system included using a transplantable syngeneic mouse model characterized by orthotopic growth of osteosarcoma in BALB/c mice at appendicular sites with spontaneous metastasis to the lung. She used this model to study the role of eukaryotic initiation factor 4E (eIF4E) in the various steps of the metastatic cascade in osteosarcoma. The title of her dissertation was “The role of eukaryotic initiation factor 4E (eIF4E) in osteosarcoma metastasis”. Members of her graduate guidance committee included: Wanda Haschek-Hock, BVSc, PhD, Diplomate, American College of Veterinary Pathologists and American Board of Toxicologists (Chair), Chand Khanna, DVM, PhD, Diplomate, American College of Veterinary Internal Medicine, Matthew A. Wallig, DVM, PhD, Diplomate, American College of Veterinary Pathologists, Lois L. Hoyer, PhD, and Timothy M. Fan, DVM, PhD, Diplomate, American College of Veterinary Internal Medicine.  Dr. Osborne joined the National Toxicology Program (NTP) Pathology Group at the National Institutes of Health Sciences (NIEHS) in 2012 as a Toxicologic Pathology Research Fellow. She participated in the design, evaluation, and interpretation of toxicity and carcinogenicity studies conducted at NTP contracted laboratories.  She gained invaluable experience in rodent toxicology studies and was able to contribute to the establishment of standards, nomenclature, and diagnostic criteria for rodent pathology.  Her fellowship allowed continued education toward enhancing molecular pathology techniques and specialized training in hepatobiliary toxicology.  She is now employed as a Project Pathologist at Novartis Institutes for Biomedical Research.   

Dr. Jones-Hall was a graduate scholar in the NCI Molecular Pathology GPP in partnership with Michigan State University and the National Cancer Institute, from 2004-2006 and 2007-2010. 

Dr. Jones-Hall obtained a bachelors of arts from Talladega College in 1999 and her doctorate of veterinary medicine from Tuskegee University in 2003. She pursued an anatomic pathology residency at Michigan State University. In 2004, she was accepted into the NCI Molecular Pathology Graduate Partnership Program to continue her graduate course work and training as a diagnostic pathologist at MSU. Captain Jones interrupted her Cancer Research Training Award training at MSU from 2006-2007 to deploy to Afghanistan in support of Operation Enduring Freedom with the United States Army Veterinary Corps. Following active duty, she returned to the program to pursue her Ph.D. dissertation research in the Cancer and Inflammation Program, Center for Cancer Research, at the National Cancer Institute located in Frederick, MD. Dr. Jones-Hall’s research topic involved studying the role of Tumor Necrosis Factor-α in the development and propagation of chemically induced colitis and colon cancer using mouse models. Her NIH principal investigator (PI) mentor was Giorgio Trinchieri, M.D. Her graduate committee members included: Dr. Trinchieri, Matti Kiupel, Dr. Med. Vet, Ph.D., Diplomate, The American College of Veterinary Pathologists, Vilma Yuzbasiyan-Gurkan, Ph.D., Alison Bauer, Ph.D., and Mark Simpson, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists. Dr. Jones-Hall received an appointment as an assistant professor at Purdue University.  In 2017, Dr. Jones-Hall became a tenured Associate Professor at Purdue University. She is now an Associate Professor in the Veterinary Pathobiology Department at Texas A&M University, College Station, TX where she serves as the director of the histology and histopathology core laboratory in the college of veterinary medicine and biomedical sciences.

Dr. (Hayes) Bouknight was a graduate Scholar in the NCI Molecular Pathology Graduate Partnership Program in partnership with Michigan State University and the National Institute of Diabetes and Digestive and Kidney Diseases, from 2005 – 2010. 

Dr. (Hayes) Bouknight received her B.S. from Fort Valley State University and her D.V.M. from Tuskegee University in 2004. After graduation, Dr. Hayes (Bouknight) pursued a residency in anatomic pathology in the Department of Pathobiology and Diagnostic Investigation at Michigan State University. In 2005, she was accepted into the NCI Molecular Pathology Graduate Partnership Program to continue graduate course work and training as a diagnostic pathologist at MSU. Following completion of her diagnostic training and course work, Dr. Hayes (Bouknight) accomplished board certification in anatomic pathology by The American College of Veterinary Pathologists in 2007. She then relocated to the NIH, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD to begin her dissertation research. Her research focused on the transcriptional regulation of adipocyte differentiation in a laboratory headed by Elisabetta Muller, Ph.D., within the NIDDK Genetics of Development and Disease Branch. Members of her graduate guidance committee included: Matti Kiupel D.V.M, Ph.D., Diplomate, The American College of Veterinary Pathologists (chair), Elisabetta Mueller, Ph.D., James Wagner,M.B.A., Ph.D., and Mark Simpson, D.V.M, Ph.D., Diplomate, The American College of Veterinary Pathologists. After receiving her Ph.D., Dr. (Hayes) Bouknight was employed by Lexicon Pharmaceuticals as a veterinary pathologist.  She now resides in Raleigh-Durham, NC where she serves as a veterinary pathologist for Charles River Laboratories.  

Shive was a graduate scholar in the NCI molecular pathology GPP in partnership with the University of Maryland and the National Cancer Institute, from 2006 to 2010. 

Dr. Shive received her B.S. from the University of Arizona and her D.V.M from North Carolina State University, College of Veterinary Medicine in 2004. Following graduation, she joined the residency program in anatomic pathology in the Department of Pathobiology at Texas A&M University, College of Veterinary Medicine, wehre she trained for two years. She was accepted as a graduate fellow in molecular pathology through the Graduate Partnership Program (GPP) at the National Cancer Institute in 2006. While pursuing graduate training at the NCI, she achieved board certification in Anatomic Pathology by the American College of Veterinary Pathologists in 2007. Dr. Shive completed her dissertation research in the research laboratory of Dennis Hickstein, M.D., in the Experimental Transplantation and Immunology Branch at the NCI. The dissertation project was focused on investigating germline mutations in the breast cancer-2 gene (brca2) in the zebrafish (Danio rerio). These studies revealed a critical role for brca2 in ovarian development, and provide new insights into brca2 mutation and cancer susceptibility. Members of her graduate guidance committee included: Siba Samal, BVSc, Ph.D., Diplomate, The American College of Veterinary Microbiologists (chair); Dennis Hickstein, M.D.; Paul Liu, M.D., Ph.D. (NHGRI); Mark Simpson, D.V.M, Ph.D., Diplomate, The American College of Veterinary Pathologists; Liangli Yu, Ph.D. and Xiaoping Zhu, D.V.M, Ph.D. After receiving her Ph.D. in 2010, Dr. Shive accepted a Staff Scientist position in the NCI, CCR, Transplantation and Immunology Branch, where she continued her cancer research using the zebrafish model.  She served as an assistant professor at North Carolina State University, Raleigh, NC for several years before moving to Ohio State University, Columbus, Ohio.